L'exocytose régulée, est un processus qui permet la communication entre les cellules à travers la sécrétion des hormones et des neurotransmetteurs. Dans les neurones et les cellules neuroendocrines, l'exocytose est strictement contrôlée par des signaux extracellulaires tels que le potentiel trans-membranaire et la fixation des ligands sur des récepteurs. Des progrès substantiels ont été effectués afin de comprendre le mécanisme moléculaire de l'exocytose. Les composants majeurs de la machinerie de sécrétion ont été dévoilés. Maintenant, la question qui émerge concerne le rôle de la plateforme de protéines qui semble avoir une action coordonnée entre chaque protéine. Dans le cas de la famille des annexines, qui est bien connue pour son action dans l'exocytose, leurs modes d'interactions séquentielles ou concertées avec d'autres protéines ainsi que leurs effets régulateurs sur l'exocytose ne sont pas encore bien établis. Des résultats précédents indiquent que l'Annexine A6 (AnxA6) affecte l'homéostasie du calcium et la sécrétion de la dopamine à partir des cellules PC12, utilisées comme un modèle cellulaire de neurosécrétion (Podszywalow Bartnicka et al., 2010). Afin de déterminer l'effet inhibiteur de l'AnxA6 sur l'exocytose de la dopamine, nous cherchons des partenaires moléculaires de l'AnxA6 dans les cellules PC12. Nous faisons l'hypothèse que l'AnxA6 interagit avec la PLD1, une enzyme active dans l'étape de la fusion des vésicules avec la membrane plasmique. En utilisant la microscopie confocale et la microscopie à onde évanescente, nous avons trouvé que l'isoforme 1 de l'AnxA6 et la PLD1 sont tous les deux recrutés sur la surface des vésicules au cours de la stimulation des cellules PC12. AnxA6 inhibait l'activité de la PLD comme indiqué par notre méthode d'analyse enzymatique au moyen de la spectroscopie infrarouge. En conclusion, nous proposons que l'AnxA6 n'est pas seulement impliquée dans la réorganisation des membranes par ses capacités à se lier avec des phospholipides négativement chargés et avec le cholestérol, mais elle influence également l'activité de la PLD1, changeant la composition lipidique des membranes / The regulated exocytosis is a key process allowing cell-cell communication through the release of hormone and neurotransmitters. In neurons and neuroendocrine cells, it is strictly controlled by extracellular signal such as transmembrane potential and ligand bindings to receptors. Substantial progress has been made to understand the molecular mechanism of exocytosis. Major components of secretory machinery have been brought to light. Now the emergent question concerns the role of scaffolding proteins that are thought to coordinate the action of each other. In the case of annexin family well known to be involved in exocytosis, their modes of –sequential or concerted- interactions with other proteins, and their regulatory effects on exocytosis are not very well established. Previous findings indicated that Annexin A6 (AnxA6) affected calcium homeostasis and dopamine secretion from PC12 cells, used as cellular model of neurosecretion (Podszywalow-Bartnicka et al., 2010). To determine the inhibitory effect of AnxA6 on exocytosis of dopamine, we were looking for molecular partners of AnxA6 in PC12 cells. We hypothesized that AnxA6 interacts with phospholipase D1 (PLD1), an enzyme involved in the fusion step. By using confocal microscopy and total internal reflection fluorescence microscopy, we found that isoform 1 of AnxA6 and Phospholipase D1 are both recruited on the surface of vesicles upon stimulation of PC12 cells. AnxA6 inhibited phospholipase D activity as revealed by our enzymatic assay based on infrared spectroscopy. To conclude, we propose that AnxA6 is not only implicated in membrane organization by its capacity to bind to negative charged phospholipids and to cholesterol, but AnxA6 is also affecting PLD1 activity, changing membrane lipids composition

As fosfolipases A2 (PLA2s) de peçonhas de serpentes compreendem um grupo de enzimas de massas moleculares variáveis entre 14.000 e 18.000, e são responsáveis por vários efeitos tóxicos induzidos pela peçonha destes animais, tornando-se necessária a busca por inibidores naturais de PLA2¬s. O presente trabalho propôs a caracterização bioquímica, farmacológica e estrutural de duas proteínas inibitórias isoladas do plasma da serpente Bothrops jararacussu (BjussuMIPs), que neutralizam as atividades enzimáticas, tóxicas e farmacológicas de diferentes PLA2s. Estes inibidores foram isolados por cromatografia de afinidade em miotoxina-Sepharose, demonstrando que ambos são glicoproteínas com massas moleculares de 24.000 (BjussuMIP) e 23.500 (BjussuMIP) para os monômeros e de 120.000 (BjussuMIP) e 160.000 (BjussuMIP) para os oligômeros. O tratamento dos BjussuMIPs com a N-glicosidase F reduziram os seus pesos moleculares para aproximadamente 18.000, mas não afetaram suas atividades inibitórias sobre PLA2s, sugerindo que os carboidratos tem pouco ou nenhum papel na associação dos BjussuMIPs com estas enzimas. A análise do BjussuMIP por dicroísmo circular mostrou 44% de -hélice, 18% de folhas , 10% de voltas e 28% de estruturas aleatórias. O cDNA obtido por PCR a partir do fígado desta serpente revelou 432 pb (BjussuMIP) e 543 pb (BjussuMIP) que codificam para 144 e 181 resíduos de aminoácidos, respectivamente. O alinhamento da sequência de BjussuMIP com a de outros inibidores do tipo , denominados de PLIs, apresentou 73-92% de similaridade e o BjussuMIP mostrou 89-94% com inibidores do tipo PLIs. Os BjussuMIPs demonstraram ser relativamente estável a variações de pH (6-12) e temperatura, entretanto, perderam atividade inibitória quando submetido a altas temperaturas. A caracterização funcional indica que os BjussuMIPs apresentaram propriedades inibitórias sobre diferentes PLA2s isoladas de peçonhas de serpentes dos gêneros Bothrops e Crotalus. Ambos BjussuMIPs revelaram propriedades farmacológicas como a inibição das atividades fosfolipásica, anticoagulante, miotóxica, indução de edema, citotóxica, bactericida e letal. Os resultados obtidos demonstram que o BjussuMIP mostra maior afinidade sobre as PLA2s homólogas Lys49 como BthTX-I e PrTX-I, enquanto que o BjussuMIP apresenta-se mais específico para PLA2s Asp49, sugerindo uma especificidade entre os BjussuMIPs e tipos de PLA2s. Além disso, ambos os inibidores mostraram ser eficazes na suplementação do antiveneno botrópico em diferentes concentrações, resultando no aumento da capacidade do soro em neutralizar toxinas de serpentes. Os aspectos abordados neste trabalho poderão trazer informações complementares sobre possíveis mecanismos de ação, podendo resultar no melhor entendimento dos efeitos inibitórios exercidos pelos BjussuMIPs, assim como auxiliar o tratamento do envenenamento ofídico pela suplementação da soroterapia tradicional. / Phospholipases A2 (PLA2s) from snake venoms comprise a group of enzymes with molecular weights varying from 14,000 to 18,000, and are responsible for several toxic effects induced by the venom of these animals, making important the search for natural inhibitors of PLA2s. The present work proposed the biochemical, pharmacological and structural characterization of two protein inhibitors isolated from the plasma of Bothrops jararacussu snake (BjussuMIPs), which neutralize the enzymatic, toxic and pharmacological activities of different PLA2s. These inhibitors were isolated by an affinity chromatography on myotoxin-Sepharose, showing that both are glycoproteins with molecular weights of 24,000 (BjussuMIP) and 23,500 (BjussuMIP) for the monomers and 120,000 (BjussuMIP) and 160,000 (BjussuMIP) for the oligomers. The treatment of BjussuMIPs with N-glucosidase F reduced their molecular weights to about 18,000, but did not affect their inhibitory activity on PLA2s, suggesting that the carbohydrates have little or no role in the association of these BjussuMIPs with these enzymes. The analysis of BjussuMIP by circular dichroism showed 44% of -helix, 18% of sheets, 10% of turns and 28% of random structures. The cDNA obtained by PCR from the snake liver showed 432 bp for BjussuMIP and 543 bp for BjussuMIP, which encode for 144 and 181 amino acid residues, respectively. The alignment of the sequence of BjussuMIP with those from other -inhibitors (PLIs) showed 73-92% of similarity and 89-94% for the BjussuMIP compared to other PLIs. The BjussuMIPs showed to be relatively stable to changes in pH (6-12) and temperature, however lost of its activity when submitted to high temperatures. The functional characterization indicates that both BjussuMIPs presented inhibitory properties on different snake venom PLA2s from the genera Bothrops and Crotalus. Both BjussuMIPs showed pharmacological properties such as inhibition of phospholipase, anticoagulant, myotoxic, cytotoxic, bactericidal, edema-inducing and lethal activities. The results show that BjussuMIP presents higher affinity to Lys49-PLA2 homologous, such as BthTX-I and PrTX-I, while BjussuMIP is more specific to Asp49-PLA2s, suggesting specificity between BjussuMIPs and types of PLA2s. Moreover, both inhibitors proved effective in the supplementation of Bothrops antivenom at different concentrations, resulting in an increased capacity of serum in neutralizing snake toxins. The issues reported in this work could bring additional information on possible mechanisms of action and may result in better understanding of the inhibitory effects exerted by these BjussuMIPs, as well as assist the treatment of ophidian envenomations by supplementation of the traditional serum therapy.

Eicosanoids are potent mediators of inflammatory response whose role has been well established in inflammatory disorders. Release of arachidonic acid by group IVA cytosolic phospholipase A2 α (cPLA2α) is the initial rate limiting step for the production of eicosonoids in response to inflammatory mediators. Previous findings from our laboratory have demonstrated that cPLA2α is directly activated by the emerging bioactive sphingolipid, ceramide-1-phosphate (C1P). In this study, we have developed a modified Triton X-100/phosphatidylcholine (PC) mixed micelle assay which was utilized to determine the kinetics and specificity of this lipid-enzyme interaction. Using this assay, the activity of the enzyme increased in a dose dependent manner with increasing amount of C1P in the mixed micelle and the stoichiometry of this interaction was found to be 2 molecules of C1P to achieve full activation. This activation was found to be lipid specific as other phospholipids such as PE, PS, PA, DAG, and S1P had insignificant effect on cPLA2α activity. Furthermore, based on previous studies we hypothesized that the specific interaction site for C1P was localized to the cationic β-groove (R57, K58, R59) of the C2 domain of cPLA2α. In this regard, mutants of this region of cPLA2α were generated ((R57A/K58A/R59A), (R57A/R59A), (K58A/R59A), (R57A/K58A), (R57A), (K58A), and (R59A)) and examined for C1P affinity by surface plasmon resonance (SPR). The triple, the double mutants, and the single mutant (R59A) demonstrated significantly reduced affinity for C1P containing vesicles compared to wild-type cPLA2α. Examining these five mutants for enzymatic activity demonstrated significant reduction in the ability of C1P to increase the Vmax of the reaction and significantly decreased the dissociation constant (KSA) of the reaction as compared to the wild-type enzyme. The mutational effect was specific for C1P as all of the cationic mutants of cPLA2α demonstrated normal basal activity as well as normal affinities for PC and PtdIns(4,5)P2 compared to wild-type cPLA2α. Finally, we demonstrated these amino acids were critical for translocation of cPLA2α in A549 lung adenocarcinoma cells in response to inflammatory agonists like A23187 and IL-1β. Lastly, we also demonstrated the mechanistic difference between activation of cPLA2α by the two anionic lipids, C1P and PI(4,5)P2.

Ceramide-1-phosphate (C1P) is a bioactive lipid that has been implicated in many biological processes. Our laboratory has conclusively demonstrated its role in inflammation via activation of cPLA2α. The only known enzyme to date responsible for direct synthesis of C1P is ceramide kinase. Very little was known about this enzyme in terms of its enzyme kinetics and substrate specificity. As CERK is an enzyme that acts on membrane lipids, its kinetics cannot be studied using standard bulk dilutions methods. Thus we developed a surface dilution approach using Triton X 100 mixed micelles for studying the kinetics of CERK. We discovered that ceramide kinase has an affinity for naturally occurring long chain ceramides while ceramides containing shorter than 8 carbons are very poor substrates for the enzyme. Also of note is the discovery that there is no discrimination between the naturally occurring long chain ceramides leading to the conclusion that the preponderance of D-e-C16 C1P in cells are due to an availability effect. We also investigated the chain length specificity of interaction between C1P and cPLA2α. Our data indicate that cPLA2α is activated by C1P’s containing acyl chains longer than two carbons. The study showed C2 C1P as being unable to activate cPLA2α thus establishing a tool for the investigation of cPLA2α dependent and independent effects of C1P. In the course of the study we investigated the ethanol/dodecane delivery system as a means of safely delivering lipids to cells. Our data conclusively demonstrate that this delivery system successfully delivers lipids to the internal membranes where their biological action takes place and that at low lipid concentration (<1µM), is non toxic to cells. A significant technical hurdle in the study of C1P was the lack of accurate and reproducible method of quantitatively and qualitatively analyzing the lipid. Using a mass spectrometric approach we developed an accurate technique that now allows us to quantify the lipids in cells. Using this and radiolabeling studies we discovered evidence for production of C1P from S1P via an acyl transferase pathway. Further studies are currently being carried out to identify the enzyme/s responsible for this pathway.

Luminescent quantum dot (QD) based probes have gained significance in the last decade for optical imaging of cells, tissues and in bioassays as alternatives to conventional organic fluorophores. The main objective of my PhD dissertation was to develop luminescent quantum dot based bioassays for real time monitoring of enzyme activity and simultaneous detection of several biomarkers. The quantum dot based bioassays developed will be potential tools in identification and diagnosis of several ailments that interfere with normal living conditions of human beings. In Chapter 2 new liposome encapsulated quantum dot based fluorescence resonance energy transfer (FRET) probes have been fabricated and characterized for monitoring the enzymatic activity of phospholipase A 2. The probes were able to detect the enzyme activity as low as 0.0075 U/mL (PLA2 = 1500 U/mg) in 30 min. Further these FRET probes were also used to screen the inhibition efficiencies of phospholipase A2 inhibitors. Chapter 3 focuses on the first time synthesis and characterization of liposome encapsulated InP/ZnS quantum dots while preserving the integrity of the liposomes. Results from the experiments to assess photostability and effect of pH on the optical properties of InP/ZnS QD-liposomes showed greater advantages over InP/ZnS quantum dots demonstrating their utility as a potential tool in several biological applications such as bio imaging, bioassays and in immunoassays. Chapter 4 discusses the development of fluorescence based immunoassay for simultaneous detection of the cardiac biomarkers troponin T and troponin I using CdSe/ZnS quantum dots. The assay achieved a detection limit was 0.1 pg/mL for both biomarkers troponin xi T and I. The method was highly specific for the both the biomarkers with no observed cross reactivity. The multiplex assay was able to detect two biomarkers simultaneously that will yield a high throughput diagnostic tool for heart attack. A similar method discussed as above was used in chapter 5 for the simultaneous detection of atherosclerosis biomarkers. The detection limits achieved in this study are comparable to the detection limits of the biomarkers reported so far. Incorporation of QDs in silica beads before conjugation to antibodies might improve detection limits that will also improve risk assessment.

Phospholipase Cβ (PLCβ) cleaves phosphatidylinositol-4,5-bisphosphate (PIP₂) into the second messengers inositol-1,4,5-triphosphate (IP₃) and diacylglycerol (DAG). IP₃ increases intracellular Ca²⁺, while DAG remains in the membrane, and together with increased Ca²⁺, activates protein kinase C (PKC). PLCβ has low basal activity but is activated following stimulation of G_i- and G_q-coupled receptors through direct interactions with Gα_q and Gβγ. PLCβ is essential for normal cardiomyocyte and vascular smooth muscle function and regulates cell proliferation, survival, migration, and differentiation. However, increased PLCβ activity and expression results in arrhythmias, hypertrophy, and heart failure. PLCβ must interact with the cell membrane for its activity. While heterotrimeric G proteins stimulate PLCβ, they are insufficient for full activation, suggesting the membrane itself contributes to increased lipid hydrolysis, potentially via interfacial activation. However, how the composition of the membrane and its resulting properties, such as surface charge, contribute to adsorption and interfacial activation is not well-established. Furthermore, whether or how interfacial activation also impacts other regulatory elements in PLCβ and Gα_q-dependent activation is unknown. Using an innovative combination of atomic force microscopy on compressed lipid monolayers and biochemical assays, we are beginning to understand how the membrane itself, PLCβ autoinhibitory elements and Gα_q regulate PLCβ activation. These studies provide the first structure-based approach to understanding how the cell membrane regulates the activity of this essential effector enzyme.

Os venenos de serpentes são misturas complexas com composição variada, possuindo constituintes orgânicos e inorgânicos. Dentre os compostos orgânicos, destacam-se as proteínas, tóxicas e/ou com altas atividades enzimáticas. Desta forma, os venenos desenvolvem importante papel na captura de presas e auxílio à digestão. Venenos de serpentes da família Viperidae apresentam ampla e variada gama de ações biológicas, como proteólise, coagulação, hemorragia, neurotoxicidade e miotoxidade. Populações de serpentes habitantes endemicamente em ilhas são bons modelos para estudos de evolução, especialmente quando comparadas a espécies de mesmo gênero que habitam o continente. Espécies ancestrais de serpentes do gênero Bothrops sofreram isolamento geográfico cerca de 9 mil anos atrás, quando no Período Pleistoceno porções de terra na região Sudeste do Brasil foram isoladas do continente, levando a formação de ilhas costeiras, devido a elevação do nível do mar. Tal isolamento deu origem a novas espécies insulares pertencentes ao gênero Bothrops. Estudos relacionados aos venenos destas espécies, suas especificidades e diferenças com relação a serpentes continentais são escassos. O Arquipélago de Alcatrazes localiza-se no litoral de São Paulo, distando aproximadamente 35 Km da costa. Não há relatos da existência de mamíferos na ilha, com exceção de morcegos. Serpentes adultas da espécie Bothrops alcatraz, endêmica da Ilha de Alcatrazes, apresentam características encontradas em serpentes juvenis do grupo das jararacas, como a dieta baseada exclusivamente em animais ectotérmicos e a composição diferenciada do veneno. O presente trabalho tem como objetivo caracterizar as principais ações do veneno da serpente B. alcatraz, espécie endêmica e ilhoa, isolando cromatograficamente suas frações. Resultados indicam no veneno de B. alcatraz apresenta as atividades coagulante sobre plasma humano, fosfolipásica, miotóxica e edematogênica mais ativas quando comparadas com as ações do veneno de B. jararaca do continente. As ações proteolítica, hemorrágica e toxicidade para camundongos são mais potentes no veneno de B. jararaca. A presença de ação neurotóxica específica para artrópodes no veneno de B. alcatraz sugere a ação de uma fosfolipase A2, a qual foi isolada cromatograficamente. As propriedades e composição do veneno de B. alcatraz indicam uma provável evolução de toxinas adaptadas a seu tipo de presa/alimento. / Snakes venoms are complex mixtures with varied composition constituted by organic and inorganic molecules. The main organic components are proteins, which can be toxic and show high enzymatic activities, thus playing important role in prey capture and digestion in snakes. Viperidae snakes family show wide range of biological actions, as proteolytic, coagulant, hemorrhagic, neurotoxic and myotoxic activities. Snake populations inhabiting endemically islands are useful models for evolution studies, specially when compared to their congeneric continental species. Bothrops species ancestors from Southeastern Brazil underwent geographic isolation about 9 thousand years ago, during the Pleistocene Period, when land portions were separated from the continent by the sea. The isolation originated new (island endemic) Bothrops species. Studies related to those snake venoms, its specialties and differences among continental species of the genera Bothrops are scarce. The Alcatrazes Archipelago is located in São Paulo coast, 35 kilometer far from the continent. There are no register of mammals in those islands, except for bats. Bothrops alcatraz is endemic from the Alcatrazes Island. Adults show some similarities to young specimens from the continental jararaca group. They feed exclusively on ectothermic animals and their venom shows a different composition. The aim of this study was to analyze the endemic island snake, B. alcatraz, venom, isolating by chromatography the venom fractions. Results indicated that B. alcatraz venom presents coagulant, phospholipase, myotoxic and edema forming activities higher than continental B. jararaca venom. The proteolytic, haemorrhagic and mice toxicity are higher on B. jararaca venom. The specific neurotoxic action in arthropods of B. alcatraz venom suggests a phospholipase A2 action, which was isolated bt cromatography. The properties and composition of B. alcatraz venom indicates a possible evolution of toxins adapted to the prey kinds.

As peçonhas de serpente do gênero Bothrops se caracterizam por induzir miotoxicidade, edema, coagulação e hemorragia. Por essa razão, alguns pesquisadores estão buscando por tratamentos alternativos contra os envenenamentos ofídicos com inibidores naturais e artificiais. O presente estudo tem como objetivo estudar as interações entre as PLA2s (Asp49 e Lys49) de veneno de serpente Bothrops jararacussu, denominadas BthTX-I e BthTX-II, respectivamente, e o inibidor vegetal isolado da espécie Cordia verbenacea. C. verbenacea apresenta diversas atividades farmacológicas já demonstradas, sendo utilizada também pela população como antiofídica. O extrato hidroalcoólico das folhas preparado à seco, foi submetido a técnicas cromatográficas como Sephadex LH-20 e CLAE, obtendo-se a purificação do princípio ativo antiofídico da planta, denominado ácido rosmarínico. A peçonha de B. jararacussu foi submetida à cromatografia de filtração em gel Sephadex G-75 e, à cromatografia de troca iônica. O ácido rosmarínico (AR) foi isolado do extrato metanólico de C. verbenacea e apresentou inibição da hemorragia provocada pela peçonha bruta de B. jararacussu. Em comparação, o ácido rosmarínico® também inibiu o efeito hemorrágico causado pela peçonha bruta de B. jararacussu. A atividade edematogênica provocada pelas toxinas BthTX-I e II foi avaliada e testada com os inibidores. Ambos AR e AR® não inibiram significativamente a induçào de edema. Resultados semelhantes foram obtidos com as atividades anticoagulante, e fosfolipásica. O ácido rosmarínico, AR e AR®, demonstrou alto efeito inibitório sobre a citotoxicidade e miotoxicidade induzida pela peçonha bruta e pela toxina BthTX-I. Ambos inibidores apresentou um menor efeito sobre a atividade miotóxica induzida pela toxina BthTX-II. Simulações de docking realizadas com três PLA2s e AR mostraram perfis de interações similares, reforçando as principais interações enzima-inibidor obtidas experimentalmente, relatadas na literatura. Os cálculos de derivação de farmacóforo baseados em diferentes inibidores relatados na literatura, assim como estudos de campos de interação molecular foram realizados, nos quais os resultados indicaram as principais modificações na estrutura do inibidor ácido rosmarínico necessárias para otimização. Nas simulações de screening virtual, novos potenciais inibidores de BthTX-I foram selecionados a partir de base de dados de compostos drug-like, direcionando os próximos passos aos testes biológicos, os quais serão realizados com esta fosfolipase e os novos candidatos a inibidores modelados. / Snake venoms from Bothrops genus are characterized by inducing myotoxicity, edema, thrombosis and hemorrhage. Thus, some researchers are searching for alternative treatments against ophidian poisoning with natural and artificial inhibitors. This work aimed study the interactions between PLA2s (Asp49 e Lys49) from Bothrops jararacussu snake venom, named BthTX-I and BthTX-II, respectively, and the inhibitor isolated from Cordia verbenacea plant. C. verbenacea presents several pharmacological activities already demonstrated, and it is also used by the population by its antiophidic activity. The hydroalcoholic extract prepared from the dried leaves, was submitted to chromatographic techniques as Sephadex LH-20 and HPLC, resulting in the purification of the antiophidian compound active from the plant, named rosmarinic acid. B. jararacussu snake venom was submitted to gel filtration chromatography on Sephadex G-75 and ion exchange chromatography. Rosmarinic acid (RA) was isolated from the C. verbenacea methanolic extract and it presented hemorrhage inhibition caused by crude venom from B. jararacussu. In comparison with this, Rosmaric acid® also inhibited the hemorrhagic effect caused by crude venom from B. jararacussu. Edematogenic activity caused by BthTX-I and II was evaluated and tested with the inhibitors. Both, RA e RA® did not inhibit the edema indution significantly. Similar results were obtained with the anticoagulant and phospholipasic activity. The rosmarinic acid, RA e RA®, presented high inhibitory effect for myotoxicity and cytotoxicity induced by crude venom and the toxin BthTX-I. Both inhibitors presented minor effect on myotoxicity activity induced by BthTX-II toxin. Docking simulations performed with three PLA2 and RA have shown similar interactions profiles, corroborating the main enzyme-inhibitor interactions experimentally obtained, reported in literature. Pharmacophore perception calculations based on different inhibitors reported in literature as well as molecular interaction fields studies were here carried out, whose results indicate the main changes in the structure of the rosmarinic acid inhibitor necessary to optimization. In the virtual screening simulations, novel potential BthTX-I inhibitors were selected from drug-like compounds databases, thus guiding next steps towards biological tests, which will must be performed with this phospholipase and the new inhibitor candidates modeled.

As fosfolipases A2 (PLA2s, ou fosfatidil-acil hidrolases EC 3.1.1.4) catalisam especificamente a hidrólise das ligações ácido-éster na posição sn-2 de glicerofosfolipídios liberando, como produto da catálise, ácidos graxos e lisofosfolipídio. São encontradas em plantas, mamíferos e em veneno de animais vertebrados e invertebrados e estão envolvidas em uma ampla variedade de processos fisiológicos. A fosfolipase A2 secretada humana do grupo IIA (hsPLA2 gIIA) é uma proteína de fase aguda da resposta imunológica, pois sua expressão é induzida por endotoxinas e citocinas via processos autócrinos e/ou parácrinos durante processos inflamatórios de relevância clínica. A hsPLA2 gIIA mostra efeito bactericida contra infecção por Staphylococcus aureus, e tem marcada preferência por fosfolipídios aniônicos tais como fosfatidilglicerol (PG) encontrados em membranas bacterianas. Uma grande variedade de inibidores de PLA2 do grupo IIA foi descrita na literatura, incluindo substâncias polianiônicas que atuam contra os efeitos inflamatórios destas enzimas. Suramina é um derivado de naftiluréia polissulfonado que recentemente mostrou ligação com os resíduos catiônicos no sítio de reconhecimento interfacial de Bothropstoxina-I (BthTX-I), uma PLA2-Lys49 isolada do veneno de Bothrops jararacussu, inibindo a atividade miotóxica da proteína. Devido ao tipo de interação diferenciada da suramina com BthTX-I em relação aos inibidores competitivos de PLA2, nós avaliamos a especificidade de ligação da suramina na hsPLA2 gIIA como um modelo para estudar este novo tipo de inibidor de PLA2s. O efeito da suramina nas atividades biológicas e de membranas artificiais da hsPLA2 gIIA foi avaliado. A suramina aboliu tanto a atividade hidrolítica da hsPLA2 gIIA quanto a atividade de danificação de membranas artificiais Ca2+ independente. Embora a suramina não tenha inibido a atividade bactericida da hsPLA2 gIIA contra a linhagem Micrococcus luteus, a ativação de macrófagos foi abolida pela mesma de maneira dependente de hidrólise. Além disso, técnicas de simulação de dinâmica molecular, calorimetria de titulação isotérmica e mutagênese sítio dirigida foram utilizadas para mapear os sítios de ligação da suramina na proteína. A interação da suramina com a hsPLA2 gIIA resultou de interações eletrostáticas entre grupos sulfonados com cadeias laterais de aminoácidos da região do sítio ativo e dos resíduos em torno das posições 15 e 116 localizados, respectivamente, na N- e Cterminal. Portanto, estes resultados permitem sugerir que a suramina pode atuar como inibidor de sPLA2s / Suramin is a polysulphonated napthylurea used as an antiprotozoal drug that presents inhibitory activity against a broad range of enzymes. We have evaluated the effect of suramin against the artificial and biological activities of the secreted human group IIA phospholipase A2 (hsPLA2 gIIA), a protein involved in inflammatory processes. To map the suramin binding sites on the hsPLA2 gIIA, proteins with mutations in the active site region and in the protein surface that makes contact with the phospholipids membrane were expressed in E. coli and refolded from inclusion bodies. The activation of macrophage cell line RAW 264.7 by hsPLA2 gIIA was monitored by nitric oxide release, and bactericidal activity of the protein against Micrococcus luteus was evaluated by colony counting and by flow cytometry. The hydrolytic activity of the hsPLA2 gIIA against lipossomes composed of a mixture of dioleoylphosphatidylcholine/dioleoylphosphatidylglycerol (DOPC/DOPG) was inhibited by a concentration of 100 nM suramin. The activation of macrophages by hsPLA2 gIIA was abolished at protein/suramin molar ratios where the hydrolytic activity of the enzyme was inhibited. In contrast, both the bactericidal activity of hsPLA2 gIIA against Micrococcus luteus and permeabilization of the bacterial inner membrane were unaffected by suramin concentrations up to 50 M. The affinity of interaction of the suramin with hsPLA2 gIIA was evaluated by suramine fluorescence and the mutants K15A, K38A, R54A and K123A presented a reduced affinity. The binding of the suramin/hsPLA2 gIIA complex was investigated by molecular dynamics simulations, which indicated two conformations of the bound inhibitor, which involve cationic amino-acid side chains in the active-site region and residues around positions 15 and 116 located in the N- and C-termini respectively in the substrate recognition surface. These results were correlated with isothermal titration calorimetry data, which demonstrated 2.7 suramin-binding sites on the hsPLA2 gIIA. These results suggested that suramin represents a novel class of phospholipase A2 inhibitor

A bothropstoxina I (BthTX-I) é uma miotoxina isolada do veneno da serpente brasileira Bothrops jararacussu, a qual é um membro da família das fosfolipases A2, mas não apresentam atividade catalítica devido á substituição D49K. A proteína for fornecida pelo Prof. Dr. J. R. Giglio e Profa. Dra. A. C. O. Cintra do Departamento de Bioquímica da Faculdade de Medicina de Ribeirão Preto e usada em experimentos de cristalização, os quais foram realizados usando a técnica de difusão de vapor \"hanging drop\" a 18°C. A BthTX-I cristalizou em tampão HEPES 0.1 M, pH variando entre 7.0 e 7.6. O agente precipitante foi o (NH4)SO4 em concentrações que variaram de 57% a 62% de saturação. A coleta de dados foi inicialmente feita utilizando o difratômetro automático R-AXIS IIC da Rigaku Co. do Laboratório de Cristalografia de proteínas do IFSC-USP. Subseqüentemente foi realizado uma segunda coleta de dados no SERC Daresbury Laboratory na Inglaterra, usando radiação síncrotron. A BthTX-I cristalizou no grupo espacial P3121 com os seguintes parâmetros de rede: a=b=57.58 ANGSTROM, c= 131.27 ANGSTROM, ALPHA=BETA=90° e GAMA=120°. O processamento de dados foi realizado com o programa MOSFLM, conduzindo a um Rmerge=6.3% e completeza de 99.6% a uma resolução de 2.1 ANGSTROM. A estrutura foi resolvida por Substituição Molecular, utilizando o programa AMoRe, onde foi utilizada como modelo inicial a estrutura da miotoxina da serpente Agkistrodon piscivorus piscivorus e refinada usando o programa XPLOR que conduziu a um fator Rfinal= 18.7% e Rfree=27.4%. A unidade assimétrica contém dois monômeros, os quais podem ser escolhidos de forma a apresentar interações similares aquelas descritas para a miotoxina II da Bothrops asper. A superfície de interface é entretanto, surpreendentemente pequena quando comparada com outras estruturas diméricas e a complementaridade é menor do que o valor esperado. Um modelo teórico para a ligação do fosfolipídeo na BthTX-I sugere que nenhuma interação direta entre a ligação ester sn-2 e a K49 deve ser esperada de forma a explicar a falta de atividade catalítica. Foi visto também, que é possível se reproduzir um dendrograma baseado na seqüência de aminoácidos, pelo uso de estruturas tridimensionais para os membros da família das PLA2 / Bothropstoxin- I (BthTX-I) is a myotoxin isolated from the Brazilian snake Bothrops jararacussu which is a member of the phospholipase A2 but presents no catalytic activity due to a D49K substitution. Protein was provided from the Departamento de Medecina de Ribeirão Preto by Prof. Dr. J. R. Giglio and Profa. Dra. A. C. O. Cintra and used in crystallization experiments which were performed using the vapor diffusion technique in hanging drops at 18°C. The BthTX-I crystallized in 0.1 M HEPES, pH ranging from 7.0 to 7.6. The precipitant was (NH4)SO4 in concentrations ranging from 57% to 62%. The data collection was initially performed using the automatic difractometer R-AXIS IIC from the Rigaku Co. at the Laboratório de Cristalografia of IFSC-USP. Subsequently a second data set was collected at SERC Daresbury Laboratory in England using synchrotron radiation. BthTX-I crystallizes in space group P3121 with a=b=57.58 ANGSTROM, c= 131.27 ANGSTROM, ALPHA=BETA=90° e GAMA=120°. Processing of the data was performed with the MOSFLM program yielding an Rmerge= 6.3% and completeness of 99.6% at 2.1 ANGSTROM. resolution. The structure was solved by Molecular Replacement using the package AMoRe with the Agkistrodon piscivorus piscivorus enzyme as search model and refined using the refinement program X-PLOR to a Rfinal= 18.7% and Rfree=27.4%. The asymmetric unit contains two BthTX-I monomers, which can be chosen such that they present similar interactions to those described for the homologous myotoxin II from Bothrops asper. The interface is, however, surprisingly small when compared to other dimeric structures and is less complementary than expected. A theorical model for phospholipid building to BthTX-I suggests that no direct interactions between the sn-2 ester bond and K49 would be expected, thus explaining the lack of catalytic activity. It is shown that it is possible to reproduce a dendrogram based on amino acid sequences and by the use of three dimensional structures for members of the PLA2 family